CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 40 filers reported holding CASI PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $156,000 | -48.9% | 192,504 | -49.6% | 0.00% | – |
| Q4 2021 | $305,000 | -68.5% | 381,710 | -53.1% | 0.00% | -100.0% |
| Q3 2021 | $969,000 | -43.8% | 814,105 | -26.8% | 0.00% | 0.0% |
| Q2 2021 | $1,724,000 | +749.3% | 1,112,208 | +1211.7% | 0.00% | – |
| Q1 2021 | $203,000 | -46.7% | 84,791 | -34.3% | 0.00% | – |
| Q4 2020 | $381,000 | -61.1% | 129,023 | -79.9% | 0.00% | -100.0% |
| Q3 2020 | $980,000 | +566.7% | 640,654 | +3485.9% | 0.00% | – |
| Q2 2018 | $147,000 | -91.8% | 17,866 | -95.8% | 0.00% | -100.0% |
| Q1 2018 | $1,794,000 | +1209.5% | 430,297 | +919.3% | 0.00% | – |
| Q4 2017 | $137,000 | +661.1% | 42,214 | +145.4% | 0.00% | – |
| Q3 2015 | $18,000 | – | 17,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,136,000 | 25.80% |
| Consonance Capital Management LP | 10,540,715 | $25,298,000 | 2.70% |
| Wellington Shields & Co., LLC | 1,832,769 | $4,399,000 | 1.58% |
| Tri Locum Partners LP | 1,500,000 | $3,600,000 | 0.89% |
| Wellington Shields Capital Management, LLC | 2,231,765 | $5,356,000 | 0.51% |
| Ghost Tree Capital, LLC | 650,000 | $1,560,000 | 0.37% |
| 1492 Capital Management LLC | 159,486 | $382,000 | 0.11% |
| Ikarian Capital, LLC | 1,268,154 | $3,044,000 | 0.10% |
| Sio Capital Management, LLC | 203,432 | $488,000 | 0.10% |
| Aristides Capital LLC | 63,250 | $152,000 | 0.06% |